Remove 2022 Remove Diagnostic Remove Nuclear Medicine Remove Radiation Oncology
article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. However, few freestanding theranostics centers exist today. Hope added.

article thumbnail

ACR responds to CMS proposed 2025 MPFS rule

AuntMinnie

The organization noted that the CMS expects the overall impact of the proposed MPFS to be neutral on radiology, nuclear medicine, and radiation oncology. The proposal would include all "topped-out" diagnostic radiology measures (i.e., However, interventional radiology will have a decrease of 2%.

Medicare 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

FAPI-PET shows promise in head and neck cancer patients

AuntMinnie

In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of Nuclear Medicine. Image courtesy of the Journal of Nuclear Medicine.

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

NorthStar to end production of Mo-99

AuntMinnie

No shortage is expected of Mo-99’s daughter decay chain isotope technetium-99m (Tc-99m), which is used in an estimated 40,000 diagnostic nuclear medicine exams each day in the U.S., said the Society of Nuclear Medicine and Molecular Imaging (SNMMI). supply of the isotope and help reduce U.S. radiopharmacy market.

article thumbnail

The rise of theranostics: Part 3 -- What is a theranostics center?

AuntMinnie

Eliot Siegel, MD; Stanislav Spiridonov, MD; Nathan Gee, MD; and Anthony Chang, PhD, are among a niche gathering of early adopters, entrepreneurial physicians, medical physicists, and investors with a sweet spot for nuclear medicine, diagnostic radiology, and radiation oncology.